These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 728319)

  • 1. Effect of surgery under general anaesthesia on antipyrine clearance.
    Pessayre D; Allemand H; Benoist C; Afifi F; François M; Benhamou JP
    Br J Clin Pharmacol; 1978 Dec; 6(6):505-13. PubMed ID: 728319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased hepatic microsomal activity after halothane anaesthesia in children.
    St Haxholdt O; Loft S; Clemmensen A; Hjortsø E
    Anaesthesia; 1986 Jun; 41(6):579-81. PubMed ID: 3728925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipyrine and metronidazole metabolism during occupational exposure to gasoline.
    Døssing M; Loft S; Sonne J; Schroeder E
    Int Arch Occup Environ Health; 1988; 60(2):115-8. PubMed ID: 3346081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of isoniazid on antipyrine clearance in man.
    Grech-Belanger O; Belanger PM; Lachance J
    J Clin Pharmacol; 1983; 23(11-12):540-4. PubMed ID: 6662978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between metabolic clearance rate of antipyrine and hepatic microsomal drug-oxidizing enzyme activities in humans without liver disease.
    Vuitton D; Miguet JP; Camelot G; Delafin C; Joanne C; Bechtel P; Gillet M; Carayon P
    Gastroenterology; 1981 Jan; 80(1):112-8. PubMed ID: 7450397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of ciprofloxacin on antipyrine metabolism.
    Ludwig E; Székely E; Csiba A; Graber H
    J Antimicrob Chemother; 1988 Jul; 22(1):61-7. PubMed ID: 3170391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of fenfluramine on disposition and rate of antipyrine elimination.
    O'Malley K; Stevenson IH; West M
    Pharmacology; 1975; 13(1):12-9. PubMed ID: 1153500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of the pharmacokinetics and metabolism of propranolol and antipyrine elicited by indwelling catheters in the rat.
    Chindavijak B; Belpaire FM; De Smet F; Bogaert MG
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1075-9. PubMed ID: 3418510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of mild thyroid dysfunction on antipyrine clearance and metabolite formation in man.
    Teunissen MW; van der Veen EA; Doodeman PJ; Breimer DD
    Eur J Clin Pharmacol; 1984; 27(1):99-103. PubMed ID: 6489432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipyrine clearance in surgical patients maintained on hypocaloric peripheral parenteral nutrition.
    Jorquera F; Almar M; Martinez C; Gonzalez-Sastre M; Culebras JM; Gonzalez-Gallego J
    JPEN J Parenter Enteral Nutr; 1994; 18(6):544-8. PubMed ID: 7602731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic metabolic ability during anaesthesia. Evaluation of antipyrine half-lives and their relation to enflurane metabolism.
    Oikkonen M; Rosenberg PH; Neuvonen PJ
    Anaesthesia; 1984 Jul; 39(7):660-5. PubMed ID: 6465491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased values of antipyrine clearance in type IV hyperlipoproteinemia.
    Bedeleanu D; Trif I; Lötsch JC; Cucuianu MP
    Med Interne; 1986; 24(3):183-90. PubMed ID: 3775212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug metabolism in malnourished children: a study with antipyrine.
    Homeida M; Karrar ZA; Roberts CJ
    Arch Dis Child; 1979 Apr; 54(4):299-302. PubMed ID: 110271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipyrine clearance and its correlation to routine liver function tests in patients with liver disease.
    Krausz Y; Zylber-Katz E; Levy M
    Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):253-7. PubMed ID: 7450926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
    Branch RA; Shand DG; Wilkinson GR; Nies AS
    J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipyrine metabolism and liver function in patients treated with high-dose medroxyprogesterone.
    Rautio A; Kauppila AJ; Tuimala RJ; Sotaniemi EA
    Biomedicine; 1979 Sep; 31(5):135-8. PubMed ID: 508896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oxidative hepatic metabolism in chronic alcoholics during the acute abstinence period: evaluation with antipyrine elimination].
    Soto Alvarez J; Alsar Ortiz MJ
    Rev Clin Esp; 1993 Jun; 193(2):60-3. PubMed ID: 8341815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma clearance of propranolol and sotalol and hepatic drug-metabolizing enzyme activity.
    Sotaniemi EA; Anttila M; Pelkonen RO; Järvensivu P; Sundquist H
    Clin Pharmacol Ther; 1979 Aug; 26(2):153-61. PubMed ID: 455885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of age on antipyrine metabolism in patients with gastric cancer.
    Higuchi T; Nakamura T; Uchino H
    J Natl Cancer Inst; 1980 Nov; 65(5):897-900. PubMed ID: 6933259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipyrin clearance in homozygous beta-thalassemia.
    Rifkind AB; Canale V; New MI
    Clin Pharmacol Ther; 1976 Oct; 20(4):476-83. PubMed ID: 975719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.